Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Endocrine, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | Any - 30 |
| Updated: | 9/2/2018 |
| Start Date: | October 2016 |
| End Date: | July 26, 2020 |
This is a retrospective chart review of patients who underwent a hematopoietic stem cell
transplant (HSCT) between 1994 and 2016 to evaluate incidence of malglycemia and the
relationship to specific outcomes.
transplant (HSCT) between 1994 and 2016 to evaluate incidence of malglycemia and the
relationship to specific outcomes.
This is a retrospective chart review of patients who underwent a hematopoietic stem cell
transplant between 2007 and 2016 to evaluate incidence and risk factors of malglycemia. The
review will also aim to characterize relationships between specific outcomes and malglycemia
in pediatric HSCT patients.
transplant between 2007 and 2016 to evaluate incidence and risk factors of malglycemia. The
review will also aim to characterize relationships between specific outcomes and malglycemia
in pediatric HSCT patients.
Inclusion Criteria:
- Age 0 to 30 years old at time of transplant
- Bone Marrow Transplant (BMT) recipient at Children's Hospital Colorado (CHCO) between
1/1/2007 and 7/31/2016
Exclusion Criteria:
- Preexisting diabetes mellitus or known hyperglycemia
- Inadequate blood glucose data for analysis
We found this trial at
1
site
Children's Hospital Colorado At Children's Hospital Colorado, we see more, treat more and heal more...
Click here to add this to my saved trials
